Randomized Study on the Efficacy and Safety of Landiolol, an Ultra-Short-Acting .BETA.1-Adrenergic Blocker, in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Randomized Study on the Efficacy and Safety of Landiolol, an Ultra-Short-Acting .BETA.1-Adrenergic Blocker, in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Published:2012 Issue:2 Volume:76 Page:439-445
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Hanada Kenji¹,Higuma Takumi¹,Nishizaki Fumie¹,Sukekawa Takanori¹,Yokota Takashi¹,Yamada Masahiro¹,Saito Shin¹,Kushibiki Motoi¹,Oikawa Koichi¹,Abe Naoki¹,Tomita Hirofumi¹,Osanai Tomohiro¹,Okumura Ken¹

Affiliation:

1. Department of Cardiology, Hirosaki University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/76/2/76_CJ-11-0947/_pdf

Reference28 articles.

1. 1. Rentrop P, Blanke H, Karsch KR, Kaiser H, Köstering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63: 307-317.

2. 2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82-e92.

3. Cardiac protection during acute myocardial infarction: Where do we stand in 2004?